Breakout Sessions I
AI in Action: Translating Technology Into Real Site Outcomes
Technology is creating genuine competitive advantages for sites that know how to evaluate and adopt it strategically. AI tools, CTMS platforms, and digital recruitment solutions are reshaping how trials are managed — and LATAM sites have a real opportunity to lead. Look at the technology landscape, including what tools are delivering results, what they actually require to implement, and how sites can make confident, informed adoption decisions that fit their context and resources.
Budget & Contract Negotiation Strategies
Sites that understand the true value of their work are better equipped to negotiate contracts that reflect it. Building a strong financial position starts with knowing exactly what it costs to conduct a trial — and being able to articulate that clearly and confidently to sponsors and CROs. This session equips LATAM sites with the tools and strategies to approach budget negotiations with knowledge, advocate for fair compensation, and build financial agreements that support sustainable site operations.
Country Roundtable — Brazil
Brazil stands in a category of its own in Latin American clinical research. ANVISA operates as a distinct regulatory authority with its own frameworks and requirements, and the landmark 2024 legislation on research involving human subjects brought unprecedented legal clarity to the conduct of trials in the country — triggering a measurable increase in study activity, particularly in early-phase research. This roundtable explores what is driving Brazil’s momentum, what it means for sites operating there today, and how to maximize the opportunity ahead.
Starting Strong: A Roadmap for Sites New to Clinical Research
Entering clinical research is one of the most rewarding decisions a site can make, and the sites that thrive build intentionally from day one. This session brings together experienced LATAM site leaders to share what they wish they had known: the infrastructure priorities, staffing decisions, sponsor relationship strategies, and early-stage milestones that set new research programs up for sustainable success.